Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis

NCT05182034 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Knee Osteoarthritis

Interventions

BIOLOGICAL: SMUP-IA-01(low dose)
BIOLOGICAL: SMUP-IA-01(mid dose)
DRUG: Active Control Group Sodium chloride

Sponsor

Medipost Co Ltd.